LTP-001

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameLTP-001
Drug Alias NameLTP-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase SMURF1 inhibitors
TargetsE3 ubiquitin-protein ligase SMURF1
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[19] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A